We have recently collaborated with a new company ICHORBIO based in Oxford (UK). ICHORBIO is supplier of research grade biosimilars and in vivo antibodies. They support in producing next Great oncology breakthrough. Part of the reason why cancer is so difficult to treat is because it is constantly mutating – and therefore the drugs they use must rapidly change and life science research must lead the way. They want to help your research to evolve as fast as cancer.